Physician profile
Robert J Kim
NPI 1912013947
$16,716.73
in general payments reported to CMS, 2019-2025
42 companies · $2,128 in 2025
The $2,128 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,721 · 2020: $1,107 · 2021: $3,104 · 2022: $3,225 · 2023: $2,491 · 2024: $1,941 · 2025: $2,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,549 · Consulting Fee: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,549.37 |
| Consulting Fee | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,165.43 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Medical Device Business Services, INC. | $1,928.89 | 2019-2021 | |
| Abbott Laboratories | $1,910.04 | 2019-2025 | Mitraclip, Aveir, Assurity |
| Biosense Webster, INC. | $1,775.13 | 2019-2025 | Carto 3, Smartablate, Qdot Micro Catheter |
| Medtronic, INC. | $1,445.00 | 2021-2025 | Onyx Frontier, Affera Mapping System, Micra |
| Cvrx, INC. | $1,043.26 | 2021-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $678.00 | 2021-2023 | Optimizer |
| Amgen INC. | $571.00 | 2021-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $534.08 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $395.99 | 2024-2025 | Impella |
| Bardy Diagnostics, INC. | $351.50 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $325.96 | 2020-2024 | Wainua, Farxiga |
| United Therapeutics Corporation | $248.87 | 2020 | |
| Pfizer INC. | $241.02 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $236.49 | 2019-2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $222.84 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.81 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $206.63 | 2020-2024 | Xarelto |
| Stryker Corporation | $193.66 | 2021-2025 | Limflow System |
| Merck Sharp & Dohme LLC | $173.87 | 2022-2025 | Verquvo |
| Angiodynamics, INC. | $158.97 | 2021 | |
| Esperion Therapeutics, INC. | $149.68 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.39 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $136.57 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $133.33 | 2022 | |
| Akcea Therapeutics, INC. | $119.24 | 2021 | |
| Cook Medical LLC | $114.68 | 2021 | |
| Philips North America LLC | $108.97 | 2023-2025 | (Ck7) Extended Holter, Extended Holter, Ambulatory Monitoring & Diagnostics Undivided |
| Bard Peripheral Vascular, INC. | $105.13 | 2024 | Venovo |
| Ethicon US, LLC | $104.78 | 2022 | |
| Acutus Medical, INC. | $102.88 | 2020-2022 | |
| Medtronic Vascular, INC. | $92.85 | 2019 | |
| Siemens Medical Solutions USA, INC. | $91.48 | 2020-2022 | |
| Cardiovascular Systems INC. | $59.77 | 2022-2023 | Diamondback Coronary |
| Cordis US Corp. | $48.04 | 2025 | Mynx Control Venous |
| Actelion Pharmaceuticals US, INC. | $46.87 | 2020 | |
| Amarin Pharma, INC. | $31.00 | 2020 | |
| Scpharmaceuticals INC. | $29.94 | 2023 | |
| Genzyme Corporation | $22.36 | 2022 | |
| W. L. Gore & Associates, INC. | $20.07 | 2025 | Gore Cardioform Septal Occluder |
| Biotronik INC. | $16.85 | 2020 | |
| Cardiva Medical, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.